BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7103519)

  • 1. Thalidomide in the treatment of Behçet's syndrome.
    Saylan T; Saltik I
    Arch Dermatol; 1982 Aug; 118(8):536. PubMed ID: 7103519
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of Behcet's syndrome with thalidomide].
    Hamza M; Chaffai M; Ben Ayed H
    Nouv Presse Med; 1982 Mar; 11(14):1080-1. PubMed ID: 7079129
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thalidomide and the treatment of Behçet's syndrome].
    Couzigou P; Doutre MS; Houdée G; Richard-Molard B; Fleury B; Amouretti M; Beylot C; Béraud C
    Gastroenterol Clin Biol; 1983; 7(8-9):751. PubMed ID: 6618080
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thalidomide and Behçet's syndrome].
    Rogé J; Testas P
    Gastroenterol Clin Biol; 1984 Feb; 8(2):196. PubMed ID: 6698358
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behçet's disease. Attempt at treatment with thalidomide].
    Bennouna-Biaz F; Benharbit R; Heid E; Senouci-Belkhadir K; Lazrak B
    Maghrib Tibbi; 1986 Jun; 8(2):301-8. PubMed ID: 3613658
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thalidomide and ulcerative colitis in Behçet's disease].
    Patey O; Charasz N; Roucayrol AM; Malkin JE; Lafaix C
    Gastroenterol Clin Biol; 1989 Jan; 13(1):104. PubMed ID: 2925035
    [No Abstract]   [Full Text] [Related]  

  • 7. Pyoderma gangrenosum associated with Behçet's syndrome--response to thalidomide.
    Munro CS; Cox NH
    Clin Exp Dermatol; 1988 Nov; 13(6):408-10. PubMed ID: 3256462
    [No Abstract]   [Full Text] [Related]  

  • 8. [Erythroleukemia in a patient with Behçet's disease under long-term thalidomide therapy].
    Louzir B; Othmani S; Gritli N; Beji M; Zidi B; M'Saddek F; Boussema E; Bahri M
    Ann Med Interne (Paris); 1992; 143(7):479-80. PubMed ID: 1300872
    [No Abstract]   [Full Text] [Related]  

  • 9. Thalidomide in Behçet's disease.
    Shek LP; Lim DL
    Biomed Pharmacother; 2002 Feb; 56(1):31-5. PubMed ID: 11908493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of Behçet's disease with lenalidomide.
    Green J; Upjohn E; McCormack C; Zeldis J; Prince HM
    Br J Dermatol; 2008 Jan; 158(1):197-8. PubMed ID: 17986298
    [No Abstract]   [Full Text] [Related]  

  • 11. Thalidomide effects in Behçet's syndrome and pustular vasculitis.
    Jorizzo JL; Schmalstieg FC; Solomon AR; Cavallo T; Taylor RS; Rudloff HB; Schmalstieg EJ; Daniels JC
    Arch Intern Med; 1986 May; 146(5):878-81. PubMed ID: 3963978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Weight gain during treatment with thalidomide: a case report].
    Comte H; Béné J; Auffret M; Gautier S; Salle-Staumont D
    Therapie; 2014; 69(5):457-9. PubMed ID: 25285366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of colitis in Behçet's disease with thalidomide.
    Postema PT; den Haan P; van Hagen PM; van Blankenstein M
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):929-31. PubMed ID: 8889464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Behçet's disease with thalidomide.
    Hamza MH
    Clin Rheumatol; 1986 Sep; 5(3):365-71. PubMed ID: 3780143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide in the treatment of neuro-Behçet's syndrome.
    Ranselaar CG; Boone RM; Kluin-Nelemans HC
    Br J Dermatol; 1986 Sep; 115(3):367-70. PubMed ID: 3756093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of recurrent perforating intestinal ulcers with thalidomide in Behçet's disease.
    Sayarlioglu M; Kotan MC; Topcu N; Bayram I; Arslanturk H; Gul A
    Ann Pharmacother; 2004 May; 38(5):808-11. PubMed ID: 15010523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide responsiveness in an infant with Behçet's syndrome.
    Shek LP; Lee YS; Lee BW; Lehman TJ
    Pediatrics; 1999 Jun; 103(6 Pt 1):1295-7. PubMed ID: 10353947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sucessful use of thalidomide in severe gastrointestinal Behçet's disease.
    Lim YK; Keating JP; Steele R
    ANZ J Surg; 2015 Jun; 85(6):496. PubMed ID: 26031928
    [No Abstract]   [Full Text] [Related]  

  • 19. Thalidomide and cell mediated immunity in Behçet's disease.
    Hamza M; Hamzaoui K; Ayed K; Eleuch M; Zribi A
    Clin Rheumatol; 1987 Dec; 6(4):608-9. PubMed ID: 3449313
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urinary incontinence secondary to thalidomide use].
    Ahrich N; Meziane M; Khatibi B; Senouci K; Hassam B; Benzekri L
    Ann Dermatol Venereol; 2008 Nov; 135(11):776-7. PubMed ID: 19061661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.